Studies by Location

CRC, a Sequoia Company

Kansas City, MO

Address

4601 Madison Ave

Kansas City

64112

Suite 210

(816) 389-5931

8:00 AM

–

5:00 PM

Monday - Friday

About this Location

CRC brings established nephrology expertise to the Sequoia network, with approximately 100 nephrology trials across common, complex and rare renal conditions.

Facility Overview

This standalone outpatient research site includes dedicated exam and clinical space and is located near hospital and emergency services.

Principal Investigator

Dr. Awad leads nephrology research at this site, bringing extensive experience across a broad range of renal indications.

Therapeutic Specialties

Sequoia Kansas City CRC specializes in nephrology research, with experience across chronic kidney disease (CKD), diabetic nephropathy, IgA nephropathy, ADPKD, FSGS, lupus nephritis and other renal indications. Sponsors seeking an experienced Phase I–IV site with deep nephrology research expertise can contact our team.

Type 2 Diabetes Study

Adults 45 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on blood sugar control and overall metabolic health.

Type 2 Diabetes & Weight Management Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on blood sugar control and weight management.

Type 2 Diabetes & Kidney Function Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on blood sugar control and kidney-related health.

Heart Failure Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand whether it may improve heart failure-related health outcomes.

Heart Failure & Weight Management Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on heart failure and weight-related health outcomes.

Chronic Kidney Disease & Metabolic Acidosis Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on acid balance and kidney-related health.

IgA Nephropathy Kidney Disease Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are evaluating an investigational treatment to better understand whether it may help protect kidney function.

Type 2 Diabetes, High Blood Pressure & Heart Health Study

Adults 18 and older

|

Male or Female

CRC, a Sequoia Company

Researchers are studying an investigational treatment to better understand its effects on blood pressure and cardiovascular health.

Earn up to $7,940

Autosomal Dominant Polycystic Kidney Disease Study

18 - 65

|

Male or Female

CRC, a Sequoia Company

We are doing this study to learn more about an experimental drug called AZD1613, and also to better understand ADPKD and associated health problems.

General Study

18 +

|

Male or Female

CRC, a Sequoia Company
Johnson County ClinTrials(JCCT), a Sequoia Company
Juno Research, a Sequoia Company (Houston, TX)
Juno Research, a Sequoia Company (Bellaire, TX)

Each study has unique goals, requirements, and participation criteria. Eligibility, compensation, and time commitments may vary.

$200 first two visits
+ $100 additional visit

Heart Failure and Impaired Kidney Function Study

18 +

|

Male or Female

CRC, a Sequoia Company

We are doing this study to learn more about how effective, safe and tolerable an experimental drug called balcinrenone is when used in combination with dapagliflozin for treating patients with heart failure and impaired kidney function and also to better understand the studied disease and associated health problems.

Earn up to $1,725

CKD Study

18 +

|

Male or Female

CRC, a Sequoia Company

We are doing this study to learn more about a new drug called AZD7760 when it is given as an intravenous (IV; into the vein) infusion to healthy adults (Phase I) or adults with end-stage kidney disease who are on hemodialysis with a central venous catheter (Phase IIa).

Earn up to $100/visit

Diabetic Kidney Disease Study

18 - 80

|

Male or Female

CRC, a Sequoia Company

This study is focused on participants who have diabetic kidney disease. The aim of this study is to see how safe and effective the study drugs are.

Earn up to $115/visit

CVD Study (18-54)

18 - 54

|

Male or Female

CRC, a Sequoia Company

This study is being conducted to find out if the study drug prevents major heart and circulation problems in people who have or are at high risk for heart disease and have high blood pressure.

Earn up to $1,625

Ebola Study

18 - 50

|

Male or Female

CRC, a Sequoia Company

This study is designed to provide the needed safety and immunogenicity data in healthy adult population to support rapid deployment of the SUDV vaccine against an ongoing or future outbreak of the Sudan strain of Ebola.

Earn up to $115/visit

CVD Study (55+)

55 +

|

Male or Female

CRC, a Sequoia Company

This study is being conducted to find out if the study drug prevents major heart and circulation problems in people who are at high risk for heart disease and have high blood pressure.

Earn up to $3,400

Heart Failure & Impaired Kidney Function Study

18 +

|

Male or Female

CRC, a Sequoia Company

We are doing this study to learn more about the benefits and safety of treatment of an experimental drug called baxdrostat in combination with dapagliflozin for treating patients with CKD and high blood pressure. We also want to better understand CKD and the health problems that come with it.